Apilak (Apilac)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbspsublingual tablets
Composition:
Active component:

Apilaka lyophilized

(Royal Jelly) with the content of the sum of unsaturated fatty acids in terms of 10-hydroxy-2-decenoic acid and dry matter 5%		 - 0.01 g
Auxiliary substances:
[sugar of milk (lactose monohydrate), potato starch, talc, calcium stearate] - a sufficient amount to prepare a tablet weighing 0.15 g
Description:Tablets are round, flat-cylindrical, with a facet, from white to white with a yellowish tinge of color with small impregnations.
Pharmacotherapeutic group:Biostimulating agent of natural origin
ATX: & nbsp
  • Tetanus preparations
    • Pharmacodynamics:

    Apilac - bee royal jelly - is a secret, produced by allotrophic glands of worker bees. As part of the apilac found vitamins, macro and trace elements, amino acids, including essential, and a number of other biologically active substances.

    The drug has a general toning effect, stimulates cellular metabolism.
    Indications:

    In the period of convalescence after the transferred diseases, with lactation (hypogalactia) in the postpartum period.

    As an auxiliary in the treatment of neurotic disorders and arterial hypotension.

    Contraindications:

    Hypersensitivity to the components of the drug, to beekeeping products; Addison's disease, age under 18 (due to lack of sufficient clinical data); deficiency of lactase, lactose intolerance, glucose-galactose malabsorption (due to the presence of lactose).

    Pregnancy and lactation:

    Use during pregnancy and during breastfeeding is possible after consultation with a doctor.

    Dosing and Administration:

    Sublingually, adults 1 tablet (10 mg) 3 times a day. The tablet should be put under the tongue and kept until completely absorbed.

    The duration of the course of treatment is 10-15 days.

    Side effects:

    Allergic reactions, insomnia.

    When allergic reactions occur, you must stop taking the drug. When insomnia should reduce the dose or cancel the drug.

    If side effects occur, consult a doctor.

    Overdose:

    To date, cases of overdose have not been reported.

    Interaction:

    Not described.

    Effect on the ability to drive transp. cf. and fur:

    The use of the drug does not affect the performance of potentially hazardous activities,requiring special attention and quick reactions (vehicle management, working with moving mechanisms, dispatcher and operator work, etc.).

    Form release / dosage:Tablets are sublingual, 10 mg.
    Packaging:

    For 10 tablets in a planar cell package.

    1, 2 or 3 contour mesh packages together with instructions for use in a pack of cardboard.

    Storage conditions:

    In a dry, the dark place at a temperature of no higher than 20 ° C.

    Keep out of the reach of children.

    Shelf life:

    3 years.

    Do not use after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:LS-000208
    Date of registration:18.05.2010
    Expiration Date:Unlimited
    The owner of the registration certificate:VIFITEH, CJSC VIFITEH, CJSC Russia
    Manufacturer: & nbsp
    Representation: & nbspVIFITEH, CJSCVIFITEH, CJSC
    Information update date: & nbsp09.09.2017
    Illustrated instructions
      Instructions
      Up